These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9371320)

  • 1. Transfusion and HIV.
    Busch MP
    Curr Opin Hematol; 1994 Nov; 1(6):438-42. PubMed ID: 9371320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission of HIV infection by seronegative blood in Thailand.
    Isarangkura P; Chiewsilp P; Tanprasert S; Nuchprayoon C
    J Med Assoc Thai; 1993 Oct; 76 Suppl 2():106-13. PubMed ID: 7822978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
    Lackritz EM
    AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transfusion-associated HIV infection].
    Gürtler LG; Eberle J; Bader L
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():7-10. PubMed ID: 8000258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
    Shang G; Seed CR; Wang F; Nie D; Farrugia A
    Transfusion; 2007 Mar; 47(3):529-39. PubMed ID: 17319836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV transmission through transfusion --- Missouri and Colorado, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(41):1335-9. PubMed ID: 20966896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala.
    Mathai J; Sulochana PV; Satyabhama S; Nair PK; Sivakumar S
    Indian J Pathol Microbiol; 2002 Jul; 45(3):319-22. PubMed ID: 12785175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
    Aggarwal V; Prakash C; Yadav S; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spread of HIV in one village in central China with a high prevalence rate of blood-borne AIDS.
    Zhang W; Hu D; Xi Y; Zhang M; Duan G
    Int J Infect Dis; 2006 Nov; 10(6):475-80. PubMed ID: 17049292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections.
    Pillonel J; Barin F; Laperche S; Bernillon P; Le Vu S; Brunet S; Thierry D; Desenclos JC;
    Transfusion; 2008 Aug; 48(8):1567-75. PubMed ID: 18482193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current aspects of HIV infection].
    Gürtler LG
    Beitr Infusionsther; 1991; 28():1-6. PubMed ID: 1725606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations.
    Tozer RA
    P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.